Bloomwell Group, a Frankfurt, Germany-based medical cannabis holding company, raised a Multi Million Euro Growth funding.
The round was led by Artemis Growth Partners with participation from Measure 8 Venture Partners, German family office and Moritz Bleibtreu.
The company intends to use the funds to accelerate its current business operations and position itself for future growth.
Led by CEO Niklas Kouparanis, Bloomwell Group is a legal private cannabis company. Founded in 2020, the company has a portfolio of operating businesses which currently includes licensed distributor, importer and product developer Ilios Santé; Europe’s cannabis telemedicine company, Algea Care; and Breezy Brands, the incubator platform for technology solutions and consumer brand building. Among other things, Breezy Brands operates Germany’s marketplace for cannabis dispensaries.
As part of the transaction, Artemis co-founder and managing member William Muecke has joined the Company’s advisory board and will serve alongside Bloomwell’s current board representatives. Mr. Muecke was previously the global co-head of healthcare services in the healthcare investment banking group at Goldman Sachs and Co. With over 30 years of experience in global financial markets, Mr. Muecke is an expert in corporate finance, mergers and acquisitions, and private equity investing.
FinSMEs
08/02/2023